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Abstract.  The NG2 chondroitin sulfate proteoglycan 
is a membrane-associated molecule of ,o500 kD with 
a core glycoprotein of 300 kD. Both the complete pro- 
teoglycan and a smaller quantity of the 300-kD core 
are immunoprecipitable with polyclonal and monoclo- 
nal antibodies against purified NG2. From some cell 
lines, the antibodies coprecipitate NG2 and type VI 
collagen, the latter appearing on SDS-PAGE as com- 
ponents of 140 and 250 kD under reducing conditions. 
The immunoprecipitation of type VI collagen does not 
seem to be due to recognition of the collagen by the 
antibodies, but rather to binding of the collagen to 
NG2.  Studies on the NG2-type VI collagen complex 
suggest that binding between the two molecules is 
mediated by protein-protein interactions rather than by 
ionic interactions  involving the glycosaminoglycans. 
Immunofluorescence double labeling in frozen sec- 
tions of embryonic rat shows that NG2 and type VI 
collagen are colocalized in structures such as the in- 
tervertebral discs and arteries of the spinal column.  In 
vitro the two molecules are highly colocalized on the 
surface of several cell lines. Treatment of these cells 
resulting in a change in the distribution of NG2 on the 
cell surface also causes a parallel change in type VI 
collagen distribution.  Our results suggest that cell sur- 
face NG2 may mediate cellular interactions with the 
extraceUular matrix by binding to type VI collagen. 
p 
ROT~O~LVCANS constitute a rapidly expanding  fam- 
ily  of  glycoproteins  exhibiting  a  high  degree  of 
variability  in both their polypeptide and polysaccha- 
ride components (reviewed  by Hassell et al.,  1986;  Gal- 
lagher,  1989; Ruoslahti,  1988a,  1989). In keeping with the 
diversity of their  structures,  these complex glycoproteins 
have been found to be capable of interacting  with a variety 
of different types of molecules. Interactions  with proteogly- 
cans have been reported for most, if not all, extracellular  ma- 
trix molecules, including collagens  (Ruoslahti and Engvall, 
1980; Scott, 1988; Smith et al., 1985), laminin (Martin and 
Timpl,  1987; Frenette et al.,  1989;  Lander et al.,  1985), 
fibronectin  (Oldberg  and  Ruoslahti,  1982;  Saunders  and 
Bernfield,  1987; Ruoslahti  1988b),  vitronectin  (Suzuki  et 
all., 1984,  1985),  and thrombospondin (Dixit et al.,  1984; 
Sun et al., 1989). Cell surface molecules such as the neural 
cell adhesion  molecule can also have binding  sites for pro- 
teoglycans  (Cole and Burg,  1989).  In addition,  proteogly- 
cans are efficient at binding  some types of growth factors 
(Gospodarowicz et al.,  1987; Berman et al.,  1987, Segarini 
and Seyedin,  1988; Cheifetz et al., 1988). Most of these in- 
teractions appear to be ionic and are probably mediated by 
the highly  charged glycosaminoglycan  chains  of the pro- 
teoglycans.  In some cases, however, direct protein-protein 
interactions are responsible for the binding phenomena. This 
appears to be true in the case of decorin binding to fibronec- 
tin (Schrnidt et al., 1987) and to collagen (Vogel et al., 1984, 
1986). Similarly,  cytotactin can bind to the core protein of 
the cytotactin-binding  proteoglycan (Hoffman et al.,  1988), 
the  cytoplasmic  domain  of syndecan  can  bind  to  actin 
(Rapraeger et al., 1986), and the core protein of the cartilage 
proteoglycan aggrecan has a site for interaction with the link 
protein (Neame et al.,  1987; Kiss et al., 1987). Finally, the 
aggrecan  core protein is able to bind to hyaluronic  acid, a 
property it appears to share with versican (Zimmerman and 
Ruoslahti,  1989). 
We have described a proteoglycan called NG2 which ap- 
pears to have a small number of chondroitin  sulfate chains 
(<5) coupled to a core glycoprotein of 300 kD. Because of 
its tight association with the cell and the need to use nonionic 
detergent  for its solubilization,  we have proposed that NG2 
is a membrane-bound molecule (Stallcup et al., 1984). NG2 
is found in the rodent central nervous system on glial precur- 
sor cells of the 0-2A lineage  (Raft et al.,  1984).  On one 
branch of the 0-2A pathway, type 2 astrocytes continue to ex- 
press NG2, while on the other branch oligodendrocytes be- 
come NG2 negative.  Immunohistochemical staining  allows 
identification  of NG2-positive cells  in primary cultures of 
many different parts of the rat central nervous system (Stall- 
cup, 1981; Stallcup and Beasley, 1987; Levine and Stallcup, 
1987), and NG2-positive cells are seen in frozen sections of 
both immature and adult brain (Stallcup et al., 1984; Levine 
and Card,  1987). As shown in this manuscript,  we are now 
discovering NG2 expression in other tissues of the develop- 
ing  rat,  especially some types of blood vessels and  car- 
tilaginous  structures  of the head, limbs,  and spine. 
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proposed to serve as a means of linking the interior and ex- 
terior environments of the cells. On the inside they may in- 
teract with cytoplasmic or cytoskeletal elements,  while on 
the outside they may provide a means of linkage with the ex- 
tracellular matrix (Hook et al.,  1984; David and Van Den- 
Berghe,  1985;  Rapraeger  et al.,  1986).  In this report we 
present evidence that NG2 binds to type VI collagen via a 
protein-protein interaction and thus can serve as a linkage 
point for NG2-positive cells with the matrix. 
Materials and Methods 
Ceil Lines 
Three rat cell lines, 1349, Bill, and B28 (Schubert et al., 1974), and two 
human cell lines, IMR-90 (Nichols et al., 1977) and M21 (Bumol and Reis- 
feld, 1982), were grown in DME supplemented with 10% FCS (Tissue Cul- 
ture Biologicals, Tulare, CA). Cells were usually plated on standard tissue 
culture dishes (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA), 
but in some cases were grown on tissue culture dishes coated by overnight 
incubation with a 25-/~g/ml  solution of  poly-L-iysine (Sigma Chemical Co., 
St. Louis, MO). All cell lines tested negatively for mycoplasma contamina- 
tion using  an assay for adenosine  phosphorylase  (Gibeo  Laboratories, 
Grand Island, NY; Bethesda Research Laboratories,  Gaithersburg, MD). 
Purification of  NG2 
NG2 was extracted from B49 cells (4 ml of  packed cells) by homogenization 
in 20 ml of 150 mM NaCl, 10 mM Tris-HCi, 5 mM EDTA, pH 8.0, contain- 
ing 1% NP-40, 1 mM PMSF, and 50/~g/ml soybean trypsin inhibitor. After 
removal of insoluble material by centrifugation, a sample of B49 extract 
labeled with 125I by the lactoperoxidase technique was added to the supema- 
tant to serve as a tracer. This greatly facilitated the identification of  protein- 
containing fractions during the final two steps in the purification when opti- 
cal density at 280 run was extremely low. The NP-40 extract was adjusted 
to 0.6 M NaCI and applied to a DEAE-Sephadex A-50 column (50 ml bed 
volume). After  thorough washing with the 0.6 M NaCI solution, the colunm 
was eluted with the standard buffer (10 mM Tris HCi, 5 mM EDTA, 1 mM 
PMSF, 0.02% NP-40, pH 8.0) containing 1 M NaCI. Eluted material was 
passed over a Sepharose CL4B column to remove any Sepharose-adherent 
components, and the flow-through was agitated gently overnight at 4"C with 
Sepharose  CL4B  derivatized  with  either the I)31.10 or 1)120.43 mAb 
against NG2 (Stallcup et al., 1984; Levine and Card,  1987). This mixture 
was poured into a column and washed first with the standard Tris-EDTA 
buffer containing 1 M NaCI, then with Tris-EDTA containing 1 M urea. 
NG2 was ehted with Tris-EDTA containing 7 M guanidine-HC1, concen- 
trated  in an Amicon filtration device, and subjected to gel filtration on 
Sepharose CL4B in the guanidine-containing buffer. Two pools of protein- 
containing fractions were made: a leading peak and a trailing shoulder of 
this peak. These pools were dialyzed extensively against 10 mM NH4OAc, 
pH 7.4, and concentrated by lyophilization. Material in the leading peak 
from the CL4B column migrated as a broad band of •500  kD on SDS- 
PAGE, while material  from the trailing shoulder  ran as a faster moving 
smear of ,~400 kD. Treatment of  these two pools with chondroitinase ABC 
before electrophoresis resulted in production of well-defined components of 
300 and 200 kD, respectively. We believe the 300-kD component represents 
the intact core glycoprotein of NG2, since it matches the 300-kD species 
seen previously in rapid biosynthetic pulse-chase experiments (Stallcup et 
al., 1984). The 200-kD component appears to be a proteolytic fragment of 
the NG2 core protein, since it is still recognized by rabbit anti-NG2 anti- 
body. The corresponding 400-kD smear seen before treatment with chon- 
droitinase ABC apparently represents this core fragment with the glycos- 
aminoglycan chains attached. 
Antibodies 
Rabbit and mouse polyclonal antisera were prepared against purified NG2. 
mAbs against NG2 were the result of fusions between the P3×63 Ag 8.653 
cell line (Kearney et al., 1979) and spleen cells taken from Balb/c mice im- 
munized with purified NG2. Fusions and HAT selection of  hybridoma colo- 
nies were performed as described previously (Levine et al., 1984). Super- 
natants from hybridomas resulting from the selection process were screened 
for binding to purified NG2 immobilized in Falcon flexible microtest wells. 
An 125I-labeled  goat antibody against mouse immunoglobulins was used to 
detect mouse antibody bound to the NG2-coated wells. While the detailed 
properties of  most of  these mAbs will be presented elsewhere, a few relevant 
results with three of  the clones (N92, NI09, and N143) are included in this 
manuscript. 
The F84 mAb against a 95-kD neural glycoprotein has been previously 
described (Stallcup et al., 1985). Rabbit antisera against type IV collagen 
and laminin were gifts from Dr.  Eva Engvall (La Jolla Cancer Research 
Foundation, La Jolla, CA). Rabbit antibody against human type VI collagen 
was prepared by Dr.  Engvall by immunization with material eluted from 
mAb affinity columns  (Hessle  and Engvall,  1984). This  antiserum  was 
precipitated with 40% amraonium sulfate and further purified by absorption 
with human serum proteins coupled to CNBr-activated Sepbarose CL4B. 
Affinity-purified rabbit antifibronectin was provided by Dr. Erkki Ruoslahti 
(La Jolla Cancer Research Foundation, La Jolla, CA). Rabbit antitenascin 
was a gift from Dr. Mario Bourdon (California Institute of Biological Re- 
search,  La Jolla,  CA). Normal  mouse serum and goat antibody against 
mouse immunoglobulin were purchased from Calbiochem-Behring Corp. 
Fluorescein  and rhodamine-labeled  antibodies were obtained  from Tago 
Inc. (Burlingame, CA). 
Immune Precipitation and Gel Electrophoresis 
Cells were labeled with 125I using the lactoperoxidase technique (Hubbard 
and Cohn, 1972). Extracts of  the labeled cells were prepared using 1% NP- 
40 in 10 mM Tris HC1, 5 mM EDTA, pH 7.4, containing  1 mM PMSF 
(Calbiochem-Behring  Corp., La Jolla,  CA).  Insoluble  material  was re- 
moved after  10 min by centrifugation.  Aliquots of the extracts were in- 
cubated for 2 h at room temperature with the desired primary antibodies. 
In the case of rabbit antibodies, immunoprecipitation was accomplished by 
subsequent incubation with protein A-Sepharose (Sigom Chemical Co.) for 
2 h. For mouse mAbs we added normal mouse serum as carrier followed 
by  goat  antibody  against  mouse  immunoglobulin  to  form an  immune 
precipitate. In both cases the precipitates were washed three times with PBS 
containing 0.2% NP-40 and 0.02% SDS, then dissolved in electrophoresis 
sample buffer containing 20% glycerol and 3% SDS. In cases where re- 
duction  of disulfide bonds  was desired,  the sample buffer included 5 % 
2-mercaptoethanol. 
SDS-PAGE was performed using slab gels with a gradient  of 3-20% 
acrylamide (Laemmli, 1970). A stacking gel of 2.5% was used. Gels were 
dried under vacuum and used for autoradiography with Kodak XAR-5 film. 
Immunofluorescence 
Immunofluorescence with cell lines was performed  using living cells on tis- 
sue culture dishes. All antibodies were diluted into Hepes-buffered DME 
containing 2% FCS. The Hepes-DME-FCS solution was also used for the 
washes. Cells were incubated with primary  antibodies for 30 rain,  then 
washed three times. They were incubated with secondary antibodies for an- 
other 30 rain, washed three more times, then fixed with 95% ethanol for 
5 rain. After drying, they were coverslipped in 90% glycerol, 0.1% M Tris, 
pH 8.0. 
For immunofluorescence with frozen sections we used embryonic day 16 
rat tissue fixed by immersion for 6 h in cold 2% paraformaldehyde, pH 7.5. 
After additional overnight incubation in cold 2 % paraformaldehyde con- 
taining 25 % sucrose, the tissue was embedded in OCT and frozen in liquid 
nitrogen. 15-~m  sections were cut on a Reichardt cryostat and mounted on 
gelatin-coated slides. Sections were incubated overnight at 4"C with pri- 
mary antibody diluted in potassium PBS (KPBS) containing 2%  normal 
goat serum and 0.1% Triton X-100. After three 5-rain washes in the KPBS- 
NGS-Triton solution, the sections were incubated for another 2 h with sec- 
ondary antibody. Finally, the sections were washed three times in KPBS- 
NGS-Tritoa,  rinsed once in  He0,  and coverslipped  in glycerol-Tris as 
above. 
Immunolabeled preparations were examined with a Nikon optiphot mi- 
croscope equipped for epifluorescenee and phase contrast optics.  Photo- 
graphs  were taken using Kodak Tri-X 400 film. 
Results 
Coimmunoprecipitation of NG2 and 1)pc VI Collagen 
We previously showed that when detergent extracts of 125I- 
labeled cell lines were treated with anti-NG2 antibodies, two 
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lagen (C6), type IV collagen ((?4), and laminin (LN) from B49 
cells. B49 ceils were t2sI labeled using the lactoperoxidase tech- 
nique and extracted with  1%  NP-40. Rabbit antibodies against 
NG2, type VI collagen, type IV collagen, and laminin were used 
to prepare immunoprecipitates from this extract. Immunoprecipi- 
tares were analyzed by SDS gel electrophoresis followed  by autora- 
diography to identify labeled components. (,4) Reducing condi- 
tions; (B) nonreducing conditions. Molecular mass standards (in 
kD) are shown at lei~  and fight. Under both reducing and nonredue- 
ing conditions the extra bands in NG2 immunoprecipitates appear 
identical to type VI collagen. 
major  components  could be  immunoprecipitated and re- 
solved under reducing conditions on SDS-PAGE.  The first 
was a glycoprotein of 300 kD, and the second was a chon- 
droitin sulfate proteoglycan which migrated as a broad smear 
with an approximate size of 500 kD. Trealanent  of the im- 
mune precipitates with chondroitinase ABC quantitatively 
converted the 500-kD  proteoglycan into the 300-kD  core 
protein (Stallcup et al., 1984).  Subsequently, we have found 
that treatment with chondroitinase AC produces an identical 
effect,  suggesting  that  NG2  may  not  contain  dermatan 
sulfate. 
With a few NG2-positive cell lines such as B49, an addi- 
tional major component of 140 kD is consistently seen in 
rabbit anti-NG2 immunoprecipitates.  Occasionally, a  less 
distinct band of 250 kD is also observed (Fig.  1 A). Under 
nonreducing conditions (Fig.  1 B),  the  140- and 250-kD 
components are not present and are replaced by a very high 
molecular mass band that does not migrate very far into the 
gel. Since the mobility of the NG2 proteoglycan and core 
protein are not atfected by the nonreducing conditions, it 
seems unlikely that the unknown component(s) is structur- 
ally related to NG2 (for example, as a proteolytic fragment). 
Instead,  it  is  probably  a  distinct molecule  stabilized by 
disulfide bonds. We were able to rule out a number of  possi- 
bilities by performing immune precipitations with antibodies 
against extracellular matrix molecules known to be highly 
aggregated under nortreducing conditions. The examples of 
type IV collagen and laminln are shown in Fig. 1. Fibronec- 
tin, tenascin, and thrombospondin are other molecules that 
did not match the components seen in the NG2 immunopre- 
cipitate. Antibodies against type VI collagen, however,  im- 
munoprecipitated components that were identical to the un- 
known bands on both reducing and nonreducing gels. The 
heavily labeled 140-kD band corresponds to type VI colla- 
gen light chains, while the 250-kD band matches the heavy 
chain (Hessle and Engvall, 1984;  Engvall et al.,  1986). 
mAbs against human type VI collagen (Hessle and Eng- 
vail, 1984; Engvall et al., 1986) failed to cross react with rat 
type VI collagen in our immunoprecipitation experiments. 
However, when used with lzSI-labeled extracts from the hu- 
man melanoma cell line M21,  antitype VI collagen mono- 
clonals such as 3C4 precipitated a component which, under 
reducing conditions, migrated identically to the 140-kD spe- 
cies seen in anti-NG2 precipitates prepared from B49 cells 
(not  shown).  Under  nonreducing conditions this  140-kD 
Figure  2.  Immunoprecipitations of  t25I-labeled 
NG2, type VI collagen (C6), and F84 glycopro- 
tein from 1349 cells. N143, N109, and N92 are 
mAbs against NG2. (A) Precipitations from 1% 
NP-40; (B)  precipitations from  1%  NP-40 and 
0.5% SDS. All electrophoresis was done under 
reducing  conditions. Molecular mass standards (in 
kD) are shown  at left. Type  VI collagen (seen here 
chiefly as 140-kD light chains) is immunoprecipi- 
tated only when NG2 is immunoprecipitated. 
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high molecular mass component that comigrated with the 
large aggregates shown in Fig. 1 B for B49 cells. These mAb 
data support our identification of the anti-NG2 immunopre- 
cipitable material as type VI collagen. We cannot explain 
with certainty why the 250-kD heavy chain is often absent 
from the autoradiograms in the case of both B49 and M21 
cells. One possible explanation is that, relative to the light 
chain, the heavy chain is poorly labeled by the lactoperoxi- 
dase iodination procedure, so that it does not show up well 
on the autoradiograms. The fact that it is present, albeit in 
an unlabeled state, is indicated by the existence of the very 
large aggregates on SDS gel electrophoresis performed un- 
der nonreducing conditions. The lz~I label in the case of the 
unreduced aggregate is supplied by the light chains. We have 
therefore continued to use the presence of the 140-kD light 
chains on our autoradiograms as an indicator of  the presence 
of type VI collagen, even in cases where labeled heavy chain 
is not seen. 
Several possibilities exist to explain the ability of rabbit 
anti-NG2 to precipitate type VI collagen along with NG2. 
(a) The rabbit antiserum might be contaminated with anti- 
type VI collagen activity; (b)  type VI collagen could be 
nonspecifically bound to or trapped in the immune precipi- 
tates; (c) NG2 and type VI collagen might share an antigenic 
determinant; (d) the NG2 core protein might be a type VI 
collagen heavy chain; or (e) NG2 and type VI collagen could 
form  a  specific  complex  that  is  immunoprecipitated by 
anti-NG2. 
To evaluate possibility a we performed immune precipita- 
tions  with  several  mAbs  against NG2.  These  should be 
monospecific and uncontaminated with activity against type 
VI collagen. Fig. 2 shows that mAbs N143 and N109 precipi- 
tate both NG2 and type VI collagen, just as seen with rabbit 
anti-NG2, mAb N92 fails to recognize any components in 
the NP-40 extract. However, if the extract is partially dena- 
tured with 0.5 % SDS, mAb N92 also precipitates both NG2 
and type VI collagen. An unrelated mAb that immunopre- 
cipitates the 95-kD F84 glycoprotein does not immunopre- 
cipitate type VI collagen. These results with mAbs rule out 
the possibility that contaminating antibodies against type VI 
collagen are responsible for the coimmunoprecipitation of 
NG2 and type VI collagen. They also show that type VI col- 
lagen is not nonspecifically bound to immunoprecipitates 
(possibility b), since type VI collagen is not seen in the case 
of F84 or in the case of mAb N92 in the absence of SDS. 
Type VI collagen is only immunoprecipitated in cases where 
NG2 is immunoprecipitated. 
One further inference can be made from the mAb data. 
While all three of  the monoclonais recognize epitopes on the 
300-kD NG2 core protein, only N109 recognizes an epitope 
on the 200-kD proteolytic fragment obtained as a side prod- 
uct of NG2 purification (see Materials and Methods). Fur- 
thermore, as shown in Fig. 2, N143 recognizes an epitope 
present on the native polypeptide, while N92 recognizes an 
epitope that is exposed only after partial denaturation of the 
polypeptide in SDS. Therefore, we believe that N109, N143, 
and N92 recognize three distinct determinants on the NG2 
core protein. Preliminary immunoblotting  experiments using 
CNBr fragments of NG2 also support this conclusion. Thus, 
if alternative c concerning shared determinants is to be cor- 
rect, NG2 and type VI collagen would have to share not just 
one antigenic determinant, but three separate determinants. 
This seems unlikely unless alternative d is true, i.e., that the 
NG2 core protein is actually a collagen heavy chain. This 
possibility also appears improbable, since the NG2 core pro- 
tein is distinguishable from the collagen heavy chain on our 
reducing gels, and more importantly the core protein does 
not form part of a large aggregate under nonreducing condi- 
tions, as one would expect for a collagen heavy chain. Fi- 
nally, the available amino acid sequence for the carboxy- 
terminal half  of NG2, deduced from the nucleotide sequence 
of eDNA clones (Nishiyama, A., K. Dahlin, J. Johnstone, 
J.  Prince,  and  W.  Stallcup,  manuscript  in  preparation), 
shows little or no similarity to that of the type VI collagen 
heavy chain (Chu et al.,  1990;  Bonaldo et al.,  1990). 
This leaves us with alternative e,  that type VI collagen 
binds  to  NG2  and is  coprecipitated  as  part of an  NG2- 
collagen complex.  We performed several  experiments  to 
study the nature of this complex. Fig. 3 shows that the com- 
plex is not disrupted by incubation with 1 M NaCI or with 
0.5% SDS.  However,  boiling in the presence of 0.5% SDS 
before immune precipitation results in loss of type VI colla- 
gen from the complex.  Apparently, this treatment is suf- 
ficient to disrupt the NG2-collagen interaction. These re- 
suits suggest that the binding between the two molecules 
is too strong to be mediated by ionic interactions between 
collagen and the chondroitin sulfate chains of NG2. This hy- 
pothesis is strengthened by the finding that the absence of 
chondroitin sulfate from the NG2 core protein does not affect 
its ability to bind type VI collagen during immune precipita- 
tion (Fig. 3 B). For this experiment we used B49 cells grown 
in the presence of p-nitrophenylxyloside to prevent attach- 
ment of  the glycosaminoglycan  chains to the core protein. As 
a result of this treatment we see the disappearance of the het- 
erodisperse proteoglycan band along with a large increase in 
the quantity of 300-kD core protein. The quantity of type VI 
collagen  in  the  precipitates  is  unchanged,  however,  as 
reflected by the continued presence of the 140-kD light chain 
component. (The 250-kD heavy chain is not visible on this 
autoradiogram.) Identical results were obtained when we 
treated B49 cells with chondroitinase ABC before lz~I label- 
ing, extraction with NP-40,  and immunoprecipitation. 
The chief problem with the model proposing an NG2- 
collagen complex is the finding that antitype VI collagen 
does not coprecipitate NG2. We suspected that this could be 
due to a disruptive effect of  the collagen antiserum on the sta- 
bility of  the putative NG2-collagen complex. To test this idea 
we performed clearing experiments with both the anti-NG2 
and anticollagen antibodies. Fig.  4  A  shows  the result of 
clearing the B49 extract with antibody against NG2.  Al- 
though a small amount of  type VI collagen is left in the super- 
natant after two rounds of anti-NG2 clearing, most of the 
collagen is associated with NG2 in the precipitates. How- 
ever, in the converse experiment, after clearing of a parallel 
1349 extract with antibody against type VI collagen, very lit- 
tle collagen is found to be associated with the NG2 precipi- 
tate. This is what we would expect if antitype VI collagen 
causes dissociation or interferes with re.association  of the 
complex. 
The fact that some type VI collagen remains in solution af- 
ter NG2 has been cleared from the extract in Fig. 4 A suggest 
that there may be molecules of type VI collagen and mole- 
cules of NG2 that are not present in the form of an NG2- 
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tion of l~I-labeled NG2 and 
type VI collagen (C6)  from 
1349 cells.  (A) Precipitations 
were  done  from  control  ex- 
tracts  containing  1%  NP-40 
(con), extracts  containing 1% 
NP-40 plus 0.5% SDS (SDS), 
and extracts boiled in 1% NP- 
40 and 0.5 % SDS (SDS boil). 
The 140-kD component is no 
longer  seen  in  the  immuno- 
precipitate after boiling of the 
extract with SDS. (B) Precipi- 
tations were done using con- 
trol IM9 cells (con) and B49 
cells grown for 4 d in 2 mM 
p-m'trophenylxyloside  (Xyl). 
Some NG2precipitations were 
done from 1% NP-40 (NG2), 
some from 1% NP-40 and 1 M 
NaCI (NG2 NaCl), and some 
from  1%  NP-40  and  0.5% 
SDS (NG2 SDS). The absence 
of chondroitin sulfate  chains 
from the 300-kD core protein 
from  xyloside-treated  cells 
does not alter the coprecipita- 
tion  of the  140-kD  type  VI 
collagen band. 
collagen complex. The existence of this non-NG2-precipit- 
able pool of type VI collagen in Fig. 4 A also reinforces our 
earlier conclusion that anti-NG2 does not directly recognize 
type VI collagen, but precipitates  it indirectly as part of a 
complex. 
Colocalization of NG2 and 7)~e VI Collagen 
If there is an interaction between NG2 and type VI collagen, 
we would expect this to be reflected in the distribution of the 
two molecules on cells that express both components.  We 
Figure 4.  Clearing  experiments  using anti-NG2 
and antitype VI collagen (C6) antisera.  (A) Half 
of the  l~I-labeled  1349 cell  extract was cleared 
twice (NG2 1 and NG2 2) with rabbit anti-NG2. 
The supematant was divided in half and subjected 
to further precipitation with rabbit anti-NG2 (NG2 
3) or rabbit antitype VI collagen (C6).  (B) The 
other half of the B49 extract was  cleared twice 
with rabbit antitype VI collagen (C6 1 and C6 2). 
The supernatant was divided in half and subjected 
to further precipitation with antitype VI collagen 
(C6 3) or anti-NG2 (NG2). 
Stallcup et al. NG2 Proteoglycan  and Type VI Collagen  318I ~
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 used immunofluorescence double staining to examine the 
distribution of  NG2 and type VI collagen on several cell lines 
(Fig. 5). We found the staining patterns for NG2 and type 
VI collagen to be very similar on three cell lines, B49, B111, 
and LMR-90, that express both molecules. The staining pat- 
terns were punctate in appearance and colocalized to a high 
degree. Culturing 1349 cells in the presence of ascorbic acid, 
a cofactor for prolyl and lysyl hydroxylases (Engvall et al., 
1986),  increased the intensity of type VI collagen staining, 
but did not change the punctate nature of the staining or the 
colocalization with NG2. In contrast, the NG2-negative cell 
line B28 stained quite differently with antitype VI collagen; 
the collagen is present in a very fibrillar pattern. Using B49 
cells we compared the distribution of NG2 to that of several 
other cell surface and matrix molecules (Fig. 6).  Type IV 
collagen, fibronectin, and F84 are quite different in distribu- 
tion from NG2. Laminin has a somewhat similar punctate 
appearance, but is not colocalized with NG2 to the degree 
seen with type VI collagen. 
If NG2 and type VI collagen form complexes on the cell 
surface, we would expect changes in the distribution of NG2 
to affect the distribution of collagen. One means of altering 
the distribution of  NG2 is to grow the 1349 cells on substrates 
of different adhesivity. On B49 cells grown in regular tis- 
sue culture dishes NG2 is often found to be concentrated 
along the edges of cells. On 1349 cells attached to poly-L- 
lysine-coated dishes, however,  NG2 is much more evenly 
distributed over the cell surface (Fig. 7, A-D). In both of 
these cases,  type VI collagen codistributes with NG2.  A 
more drastic change in NG2 distribution can be obtained by 
overnight incubation of the cells with anti-NG2 antibody. As 
shown in Fig. 7, E-L with Bill cells, this treatment causes 
patching or capping of NG2 into large clusters. Type VI col- 
lagen is also colocalized in these clusters after anti-NG2 
treatment. In contrast, laminin remains spread over the cell 
surface and is not cocapped with NG2. It should be noted 
that antitype VI collagen will cause capping of type VI colla- 
gen without producing cocapping  of NG2.  This  appears 
analogous to the failure of this antiserum to coprecipitate 
NG2 in our earlier results. 
Finally, if  the NG2-collagen interaction is relevant for nor- 
real cells, we should find examples of colocalization of the 
two molecules in vivo. We were unable to find type VI colla- 
gen associated with the NG2-positive glial progenitor cells 
in the central nervous system. In fact, no type VI collagen 
was seen in the brain. However,  some of the blood vessels 
associated with the membranes surrounding the brain were 
stained by both anti-NG2 and antitype VI collagen. This was 
also seen in the periphery where a number of  arteries showed 
striking colabeling with the two antibodies. The example of 
arteries in the spinal column of the embryonic day 16 rat is 
shown in Fig. 8, A-C and G-L The intervertebral disks of 
the spine provide another good example of co-localization of 
NG2 and type VI collagen (Fig. 8, A-C and D-F). These pic- 
tures also show examples of structures such as the develop- 
ing vertebrae which are  NG2-positive,  type VI collagen- 
negative, and connective tissue which is NG2-negative, type 
VI collagen positive. Thus, as with the cell lines, there are 
cases in which the two molecules are not coexpressed. How- 
ever, there are clearly good examples of in vivo colocaliza- 
tion to validate our studies with the cell lines. 
Discussion 
We have presented two types of evidence for an interaction 
of the  NG2  proteoglycan with  type VI  collagen:  coim- 
munoprecipitation and immunofluorescence colocalization. 
The immunoprecipitation experiments show that anti-NG2 
antibodies coprecipitate type VI collagen along with NG2 
proteoglycan and core protein. The fact that this coprecipita- 
tion is observed with both rabbit anti-NG2 and several differ- 
ent mAbs against NG2 argues that the phenomenon is not 
caused either by contamination of the rabbi antiserum with 
anticollagen activity or by recognition of an epitope that is 
shared by NG2 and type VI collagen. Furthermore, since 
type VI collagen is not seen in immunoprecipitations with 
antibodies against molecules other than NG2, the interaction 
of NG2 and type VI collagen must be a specific one that is 
not caused by general stickiness of the two molecules~ Since 
we have looked only at the immunoprecipitati0n of mole- 
cules  that  are  labeled  with  125I by  the  lactoperoxidase 
method, our experiments do not rule out the possibility that 
other unlabeled molecules may also bind to the NG2 pro- 
teoglycan. This  is,  of course,  a  subject of some interest 
which needs to be pursued. 
Attempts to understand the nature of the NG2-collagen 
complex suggest that the glycosaminoglycan chains of NG2 
are not required for binding. For example, a complex of  NG2 
core protein and type VI collagen is still seen in NP-40 ex- 
tracts  of cells  treated  with  chondroitinase ABC  or  cells 
grown in the presence of p-nitrophenylxyloside. This is con- 
sistent with experiments which show that the complex in 1% 
NP-40 is not affected by addition of 1M NaCI or 0.5% SDS. 
However,  boiling in 1% NP-40 plus 0.5% SDS dissociates 
the complex so that only NG2 is precipitated by anti-NG2 
antibodies. Thus, the binding is probably mediated by pro- 
tein-protein interactions rather than by weaker interactions 
involving chondroitin sulfate chains. 
The interaction between NG2  and type VI collagen is 
reflected in their codistribution on several cell lines that we 
examined using immunofluorescence double staining. The 
fact that there is not a perfect one to one correspondence be- 
tween the NG2 and type VI collagen staining patterns may 
indicate that not all type VI collagen is complexed with NG2 
(or vice versa). Our immunoprecipitation clearing experi- 
ments (Fig. 4) also suggests that this is the case. It is interest- 
ing to note that the fibrillar distribution of type VI collagen 
on the NG2-negative cell line B28 is quite different from its 
punctate distribution on NG2-positive cell lines. NG2 might 
be responsible for organizing collagen molecules on these 
cell lines. The close colocalization of NG2 and type VI col- 
lagen is  in  sharp contrast to the  lack of correspondence 
between NG2 and several other matrix molecules we exam- 
ined. Type IV collagen, fibronectin, and laminln have notice- 
ably different patterns of expression from that seen with 
NG2. Furthermore, perturbation of NG2 distribution on the 
cell surface (by plating cells on different substrates or by 
antibody-induced capping) results in parallel changes in type 
VI collagen distribution, suggesting once again a linkage be- 
tween the two molecules. 
One of our primary foci with NG2 to date has been the 
expression of the proteoglycan in the central nervous system 
on cells of the 0-2A  lineage.  Using  immunofluorescence 
double labeling we have been unable to detect type VI colla- 
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 gen expression  on these  NG2-positive  glial  cells.  During 
these studies, however, we found NG2 and type VI collagen 
immunoreactivity in several other tissues of the developing 
rat. A detailed description of the distribution of NG2 will ap- 
pear elsewhere, but for the present discussion it is important 
to note that there are areas in which NG2 and type VI colla- 
gen are colocaiized. This occurs most prominently in some 
of the  blood  vessels  in  the  thoracic  cavity,  in the  spinal 
column, and in the intestines. Coexpression is also found in 
the intervertebral  discs of the spine as well as in the tissue 
surrounding  cartilaginous structures  in the head. These ex- 
amples show that our findings with clonal cell lines are rele- 
vant to interactions that can occur in vivo. It will be impor- 
tant to examine the in vivo preparations  in more detail to 
determine what cell types are responsible for coexpression 
of NG2 and collagen. 
The NG2-type VI collagen interaction may be important 
for organization of the extracellular matrix, for binding of 
cells to the matrix, and for determination of cell morphology 
in relation to the matrix. Type VI collagen is thought  to be 
an important component of thin 3-5-nm microfibrils that in- 
teract with larger interstitial  fibers containing types I and III 
collagen (Sakai et al., 1986; Keene et al., 1988). It has been 
suggested that the type VI collagen present in ligaments is 
associated  with chondroitin sulfate proteoglycans  (Bray  et 
al.,  1990).  Binding to NG2 would provide the collagenous 
network with a point of attachment  on the cell surface.  Addi- 
tional points of attachment  are provided by molecules such 
as fibronectin and vitronectin which bind both to collagens 
and to cell surface receptors (or integrins) anchored in the 
cell membrane (Ruoslahti, 1988b). Since integrins can inter- 
act with the cytoskeleton,  the collagen-fibronectin-integrin 
linkage  provides  one  means  of signal  transmission  from 
the extracellular  matrix across the  cell membrane to the 
cytoskeleton.  Based  on  its  detergent  solubility  (Stallcup 
et al., 1984) and our tentative identification of a membrane- 
spanning domain near the carboxy terminus (Nishiyama, A., 
K. Dahlin, S. Johnstone, J. Prince, and W. Stallcup, manu- 
script  in  preparation),  we  believe  NG2  is  a  membrane- 
intercalated molecule. If so, then, the collagen-NG2 linkage 
may provide additional machinery  for transmembrane  sig- 
naling. 
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